|
Post by BD on Aug 19, 2013 9:01:43 GMT -5
This came in on my FlyOnTheWall feed this morning:
09:21 EDT MNKD theflyonthewall.com: MannKind will need new trials before approval, says Summer Street Summer Street said it is confident that the FDA will not approve MannKind's Afrezza Dreamboat inhaler without new large clinical trials. The firm, which does not rate the stock, believes the AFFINITY 1 trial was a failure. :theflyonthewall.com
|
|
|
Post by liane on Aug 19, 2013 9:10:43 GMT -5
Oh Good Grief!!!
|
|